Dean L. Schorno
EVP & Chief Financial Officer at Rigel Pharmaceuticals · 14 reported transactions in 1 company · latest report Sep 2, 2026
Their trades
Exercised options | Sep 2, 2026 | |||
Exercised options | Sep 2, 2026 | |||
Exercised options | Sep 2, 2026 | |||
Exercised options | Sep 2, 2026 | |||
Shares withheld for tax | Sep 1, 2026 | |||
Shares withheld for tax | Jun 1, 2026 | |||
Exercised options | Jun 1, 2026 | |||
Exercised options | Jun 1, 2026 | |||
Share award | Feb 17, 2026 | |||
Shares withheld for tax | Feb 10, 2026 |